news
BGMA response to Branded Medicines Consultation
Warwick Smith, Director General of the BGMA, has welcomed the DofH's decision not to introduce an additional price cut for branded generic medicines...
List view / Grid view
Biosimilars
news
BGMA and MHRA come together for quality forum
The British Generic Manufacturers Association will stage the next meeting of its Quality Forum – in conjunction with the MHRA - on Tuesday, February 24th...
news
Generic usage remains crucial to NHS savings and promoting innovation
Response from the British Generic Manufacturers Association (BGMA) to a new report issued today by the Academy of Medical Royal Colleges...
news
BioOutsource ramps up investment in R&D to prepare for biosimilars boom
3 November 2014 | By BioOutsource Ltd
BioOutsource Ltd. announced a major initiative in new research and development programs to support the next generation of biosimilars...
news
Auditing is theme for next BGMA Quality Forum
Auditing will be a key theme of the British Generic Manufacturers Association’s (BGMA) next BGMA Quality Forum meeting on Wednesday, November 12th which is run in partnership with the MHRA.
news
Thomas Broeer elected as new BGMA Chair
The British Generic Manufacturers Association (BGMA) has appointed Thomas Broeer, managing director of Kent Pharmaceuticals, as its new chair for the next two years.
news
BGMA welcomes EU General Court ruling against AstraZeneca
BGMA welcomes EU General Court ruling that AstraZeneca abused its dominant position by preventing the marketing of generic omeprazole.
